A Randomized, Open-Label Study of darbepoetin alfa (Novel Erythropoises Stimulating Protein, NESP) Using Fixed and Weight-Based Dosing for the Treatment of Anemia in Subjects with Non-myeloid Malignancies Receiving Multicycle Chemotherapy